Intestinal Coccidiosis

Intestinal coccidiosis is a highly prevalent and economically significant protozoal disease of domestic and wild rabbits (Oryctolagus cuniculus), caused by several species of the genus Eimeria. These obligate intracellular apicomplexan parasites primarily infect the epithelial cells of the small and large intestine, leading to enteritis, malabsorption, diarrhea, and in severe cases, dehydration, weight loss, and death. The disease is particularly devastating in young, weanling, and immunocompromised rabbits, and is a major cause of morbidity and mortality in commercial rabbitries, laboratory animal facilities, and pet rabbit populations. The disease is characterized by a spectrum of clinical presentations ranging from subclinical infection to acute, fulminant enteritis with high mortality. The most pathogenic species include Eimeria intestinalis, Eimeria flavescens, and Eimeria magna, which cause severe intestinal lesions, while Eimeria irresidua and Eimeria media are moderately pathogenic. Hepatic coccidiosis, caused by Eimeria stiedae, is a distinct entity affecting the bile ducts and liver, but intestinal coccidiosis is the focus of this entry. The disease is transmitted via the fecal-oral route through ingestion of sporulated oocysts, which are highly resistant in the environment. Understanding the complex life cycle, species-specific pathogenicity, and host immune responses is essential for effective diagnosis, treatment, and prevention.

The primary causative agents of intestinal coccidiosis in rabbits are multiple species of the genus Eimeria (phylum Apicomplexa, family Eimeriidae). Over 11 species have been identified in rabbits, with varying degrees of pathogenicity. The most clinically significant species include: Eimeria intestinalis – highly pathogenic, causes severe enteritis in the small intestine, particularly the ileum; Eimeria flavescens – highly pathogenic, affects the cecum and colon, causing severe diarrhea and high mortality; Eimeria magna – moderately to highly pathogenic, affects the jejunum and ileum, often associated with mucoid enteritis; Eimeria irresidua – moderately pathogenic, affects the small intestine; Eimeria media – moderately pathogenic, affects the small intestine; Eimeria perforans – mildly pathogenic, common but usually subclinical; Eimeria coecicola – mildly pathogenic, affects the cecum; Eimeria exigua – mildly pathogenic; Eimeria elongata – mildly pathogenic; Eimeria matsubayashii – mildly pathogenic; Eimeria piriformis – mildly pathogenic; Eimeria vejdovskyi – mildly pathogenic. The life cycle is direct and monoxenous, involving an exogenous sporulation phase and an endogenous asexual (merogony) and sexual (gametogony) phase within the intestinal epithelium. Sporulated oocysts are ingested, excyst in the small intestine, and release sporozoites that invade enterocytes. Asexual reproduction (merogony) produces merozoites that destroy host cells, leading to tissue damage and inflammation. After several generations, gametogony produces microgametes and macrogametes, which fuse to form zygotes that develop into oocysts. Oocysts are shed in feces, and under favorable conditions (temperature 20-30°C, humidity, oxygen), they sporulate within 1-3 days, becoming infective. Environmental contamination with sporulated oocysts is the primary source of infection, and oocysts are highly resistant to common disinfectants, surviving for months in moist, shaded environments.

Intestinal coccidiosis is a global disease affecting domestic rabbits (Oryctolagus cuniculus) of all breeds, as well as wild European rabbits (Oryctolagus cuniculus) and North American cottontail rabbits (Sylvilagus spp.). The disease is most prevalent in intensive rabbit production systems, where high stocking density, poor sanitation, and stress facilitate transmission. In commercial rabbitries, morbidity can reach 100% and mortality up to 50-80% in severe outbreaks, particularly in young rabbits aged 4-16 weeks. Weanling rabbits are most susceptible due to waning maternal immunity and increased exposure to contaminated environments. Adult rabbits often develop immunity after repeated exposure, but they can become carriers and shed oocysts intermittently, serving as a source of infection for susceptible animals. The prevalence of intestinal coccidiosis in pet rabbits is also significant, especially in multi-rabbit households or those with access to contaminated outdoor enclosures. Factors such as overcrowding, poor ventilation, high humidity, inadequate cleaning, and co-mingling of different age groups increase the risk of outbreaks. The disease is more common in warm, humid climates, as sporulation of oocysts is favored by temperatures between 20-30°C and high humidity. Wild rabbits can act as reservoirs, and contaminated feed, water, bedding, and fomites (e.g., shoes, equipment) can transmit the parasite. The incidence of clinical disease is higher in rabbits with concurrent infections (e.g., bacterial enteritis, viral infections) or immunosuppression due to stress, malnutrition, or corticosteroid therapy. In laboratory settings, coccidiosis can confound research studies, particularly those involving gastrointestinal physiology, immunology, and nutrition.

The pathophysiology of intestinal coccidiosis in rabbits is a complex interplay of direct parasitic damage to the intestinal epithelium, secondary bacterial overgrowth, and host inflammatory responses. After ingestion of sporulated oocysts, sporozoites are released in the small intestine and invade the enterocytes of the villi and crypts. The asexual replication (merogony) within enterocytes leads to cell lysis, destruction of the intestinal architecture, and loss of absorptive surface area. This results in malabsorption, osmotic diarrhea, and electrolyte imbalances. The severity of lesions depends on the Eimeria species and the parasite load. E. intestinalis and E. flavescens cause extensive destruction of the ileal and cecal mucosa, respectively, leading to severe hemorrhagic or mucoid diarrhea. The inflammatory response, characterized by infiltration of lymphocytes, macrophages, and heterophils, further damages the intestinal wall, leading to edema, ulceration, and necrosis. Disruption of the mucosal barrier allows translocation of commensal bacteria (e.g., Escherichia coli, Clostridium spp.) into the bloodstream, potentially causing septicemia and endotoxemia. The loss of protein-rich fluid into the intestinal lumen leads to hypoproteinemia, edema, and dehydration. In chronic infections, the intestinal villi become blunted and fibrotic, leading to persistent malabsorption and weight loss. The host's immune response, particularly cell-mediated immunity, is crucial for controlling the infection, but it also contributes to tissue damage. The release of pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6) exacerbates inflammation and fever. In severe cases, the combination of dehydration, electrolyte imbalances, and secondary bacterial infections can lead to shock and death. Additionally, the rapid turnover of enterocytes in response to damage may be insufficient to compensate for the loss, leading to mucosal atrophy and prolonged recovery.

Several intrinsic and extrinsic factors predispose rabbits to intestinal coccidiosis. Intrinsic factors include age (young rabbits, especially 4-16 weeks, are most susceptible due to immature immune systems and lack of acquired immunity), breed (some breeds may be more susceptible, but this is not well-documented), and genetic susceptibility. Stress is a major extrinsic factor, as it suppresses the immune system and increases cortisol levels, making rabbits more vulnerable to infection. Stressors include weaning, transport, overcrowding, poor husbandry, changes in diet, and concurrent diseases. Nutritional factors play a critical role: diets high in carbohydrates and low in fiber can alter the intestinal microbiota, favoring coccidial proliferation. Conversely, adequate dietary fiber (e.g., grass hay) promotes normal gut motility and a healthy microbiome, which may inhibit parasite establishment. Poor sanitation and hygiene are paramount: contaminated cages, feeders, water bottles, and bedding with sporulated oocysts increase the infectious dose. High stocking density and mixing of different age groups facilitate transmission. Environmental conditions such as high humidity, warm temperatures, and poor ventilation enhance oocyst sporulation and survival. Inadequate biosecurity measures, such as not quarantining new rabbits or using shared equipment, can introduce the parasite into a naive population. Immunosuppression due to corticosteroid therapy, pregnancy, lactation, or concurrent viral infections (e.g., myxomatosis, rabbit hemorrhagic disease) can exacerbate the severity of coccidiosis. Additionally, the use of certain antibiotics that disrupt the normal gut flora (e.g., clindamycin, lincomycin) can predispose rabbits to coccidiosis by removing competitive inhibition.

The clinical signs of intestinal coccidiosis in rabbits vary depending on the Eimeria species, the infectious dose, and the age and immune status of the host. In subclinical infections, rabbits may show no obvious signs but shed oocysts in feces, serving as a source of infection. In acute cases, the most common signs include: diarrhea, which may range from soft, pasty feces to watery, mucoid, or hemorrhagic diarrhea; anorexia and decreased feed intake; weight loss or failure to gain weight; dehydration, evidenced by sunken eyes, dry mucous membranes, and decreased skin turgor; lethargy and depression; rough hair coat and unkempt appearance; abdominal distension and pain, often evidenced by teeth grinding (bruxism) or hunched posture; and in severe cases, hypothermia, collapse, and death. Some rabbits may develop a mucoid enteritis, characterized by the passage of copious amounts of mucus, often without formed feces. Chronic infections may present with intermittent diarrhea, poor growth, and emaciation. In peracute cases, especially with E. flavescens, rabbits may die suddenly without premonitory signs. Physical examination may reveal a dehydrated, thin rabbit with a distended, doughy abdomen. Fecal staining around the perineum is common. In severe cases, rectal prolapse may occur due to tenesmus. It is important to note that hepatic coccidiosis (E. stiedae) presents with hepatomegaly, icterus, and ascites, but this is a separate entity. The clinical signs of intestinal coccidiosis are nonspecific and can be confused with other causes of diarrhea in rabbits, such as bacterial enteritis, viral infections, or dietary indiscretion.

The differential diagnoses for intestinal coccidiosis in rabbits include a wide range of infectious, parasitic, nutritional, and toxic conditions. Key differentials include: 1. Bacterial enteritis: Caused by pathogens such as Escherichia coli (enteropathogenic strains), Clostridium spiroforme (tylosis), Clostridium difficile, Lawsonia intracellularis (proliferative enteropathy), and Salmonella spp. These often present with diarrhea, fever, and systemic signs. Fecal culture, PCR, and histopathology can differentiate. 2. Viral infections: Rabbit hemorrhagic disease (RHD) caused by calicivirus, and myxomatosis caused by poxvirus, can cause systemic signs, but diarrhea is not a primary feature. RHD causes acute death with hepatic necrosis, while myxomatosis presents with skin lesions and swelling. 3. Gastrointestinal stasis (ileus): Often secondary to dietary issues, pain, or stress, leading to reduced gut motility, anorexia, and small or absent fecal pellets. Radiography may show gas-filled stomach and cecum. 4. Mucoid enteropathy: A condition of unknown etiology, often associated with high-carbohydrate, low-fiber diets, leading to excessive mucus production in the cecum and colon. It can be differentiated by the presence of copious mucus without significant inflammation. 5. Parasitic infections: Other intestinal parasites such as Passalurus ambiguus (pinworm), Trichostrongylus retortaeformis, and Giardia spp. can cause diarrhea, but are less common. Fecal flotation and PCR can identify these. 6. Dietary indiscretion or toxicosis: Ingestion of toxic plants, moldy feed, or antibiotics (e.g., clindamycin) can cause diarrhea. A thorough history and feed analysis are essential. 7. Neoplasia: Intestinal lymphoma or adenocarcinoma can cause chronic weight loss and diarrhea, but is rare in young rabbits. 8. Inflammatory bowel disease: Idiopathic, can cause chronic diarrhea and weight loss. Diagnosis is by exclusion and histopathology. 9. Hepatic coccidiosis (E. stiedae): Presents with hepatomegaly, icterus, and ascites, and can be differentiated by liver enzyme elevation and ultrasound. 10. Antibiotic-associated enterotoxemia: Due to disruption of normal gut flora, often caused by oral antibiotics, leading to overgrowth of Clostridium spp. and toxin production. A history of antibiotic use is key.

The diagnostic approach to intestinal coccidiosis in rabbits should be systematic and include the following steps: 1. History and signalment: Obtain a detailed history including age, diet, housing, sanitation, recent introductions, and any previous treatments. Young rabbits (4-16 weeks) with diarrhea and poor growth are highly suspect. 2. Physical examination: Perform a thorough physical exam, assessing hydration status, body condition, abdominal palpation, and perineal soiling. Note any signs of pain or distress. 3. Fecal examination: Collect fresh fecal samples (at least 3-5 grams) from multiple rabbits, especially those with diarrhea. Perform fecal flotation using a solution with a specific gravity of 1.2-1.3 (e.g., Sheather's sugar solution) to concentrate oocysts. Quantify oocysts per gram of feces (OPG) using a McMaster counting chamber. A high OPG (>10,000) is indicative of clinical coccidiosis, but low counts can be seen in carriers. 4. Fecal smear: Direct smear of fresh feces can reveal oocysts, but is less sensitive than flotation. 5. Sporulation test: To differentiate species, oocysts can be sporulated in 2.5% potassium dichromate solution at room temperature for 2-3 days, then examined microscopically for morphological features. 6. Blood work: Complete blood count (CBC) and serum biochemistry may reveal dehydration (elevated total protein, packed cell volume), electrolyte imbalances (hypokalemia, hyponatremia), and in severe cases, azotemia. Eosinophilia may be present in some parasitic infections. 7. Imaging: Abdominal radiographs may show gas-filled loops of intestine, but are not specific. Ultrasound may reveal thickened intestinal walls or fluid-filled loops. 8. PCR: Molecular techniques (PCR) can detect and differentiate Eimeria species from fecal samples, providing a definitive diagnosis and species identification. 9. Necropsy: In fatal cases, post-mortem examination is essential. Gross lesions include hyperemia, edema, and thickening of the intestinal wall, with white or yellowish nodules (meronts) visible on the serosal surface. Histopathology confirms the presence of developmental stages of Eimeria in enterocytes. 10. Response to treatment: A positive response to anticoccidial therapy (e.g., toltrazuril) supports the diagnosis. It is important to rule out other causes of diarrhea, so a comprehensive diagnostic plan is recommended.

Laboratory findings in intestinal coccidiosis are nonspecific but can support the diagnosis and assess the severity of the disease. Hematology: The complete blood count (CBC) may show hemoconcentration (elevated packed cell volume, PCV) due to dehydration. White blood cell count may be normal or elevated, with a relative heterophilia and lymphopenia, consistent with stress. Eosinophilia may be present in some cases, but is not consistent. Thrombocytopenia may occur in severe cases due to endotoxemia. Serum biochemistry: Dehydration leads to elevated total protein, albumin, and globulins. Electrolyte imbalances, particularly hypokalemia and hyponatremia, are common due to diarrhea. Blood urea nitrogen (BUN) and creatinine may be elevated due to prerenal azotemia. Liver enzymes (ALT, AST) may be mildly elevated if there is hepatic involvement, but are usually normal in intestinal coccidiosis. Fecal analysis: The cornerstone of diagnosis is the detection of Eimeria oocysts in feces. Fecal flotation using Sheather's sugar solution or zinc sulfate will reveal oocysts, which are ovoid, 20-40 μm in diameter, with a thick wall. Quantification using a McMaster chamber is recommended to assess the severity of infection. OPG counts >10,000 are considered clinically significant, but counts can vary. PCR: Polymerase chain reaction (PCR) assays are available for species-specific detection of Eimeria DNA in feces, providing a sensitive and specific diagnosis. Urinalysis: Not typically performed, but may show increased specific gravity due to dehydration. Other tests: Fecal culture and sensitivity may be performed to rule out bacterial enteritis. Serum protein electrophoresis may show hypoalbuminemia due to protein-losing enteropathy in chronic cases.

Imaging modalities are not the primary diagnostic tools for intestinal coccidiosis, but they can be useful in assessing the severity of gastrointestinal disease and ruling out other conditions. Radiography: Abdominal radiographs (lateral and ventrodorsal views) may reveal gas-filled loops of the small intestine and cecum, indicating ileus. In severe cases, there may be evidence of fluid-filled bowel loops. However, these findings are nonspecific and can be seen in other causes of enteritis. Contrast radiography (barium series) is rarely performed but may show mucosal irregularities and delayed transit time. Ultrasonography: Abdominal ultrasound can be used to assess the thickness of the intestinal wall, which may be thickened in coccidiosis due to inflammation. It can also detect free fluid in the abdomen, which may indicate peritonitis. Ultrasound is more useful for evaluating the liver in cases of hepatic coccidiosis. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): These advanced imaging modalities are rarely used in the diagnosis of intestinal coccidiosis but may be helpful in detecting complications such as abscesses or neoplasia. Endoscopy: In live rabbits, upper gastrointestinal endoscopy can be performed to visualize the duodenum and obtain biopsies, but this is invasive and not commonly used for coccidiosis diagnosis. In summary, imaging is not specific for coccidiosis but can help assess the extent of gastrointestinal disease and guide further diagnostics.

Cytology and histopathology are valuable for confirming the diagnosis of intestinal coccidiosis, especially in post-mortem cases. Cytology: Fine-needle aspiration of intestinal contents or mucosal scrapings obtained at necropsy can reveal oocysts, meronts, and gamonts. Impression smears of the intestinal mucosa can be stained with Giemsa or Diff-Quik to visualize the parasitic stages. However, cytology is less sensitive than fecal flotation for detecting oocysts. Histopathology: At necropsy, the small intestine, cecum, and colon should be examined. Gross lesions include hyperemia, edema, and thickening of the intestinal wall. White or yellowish nodules (1-2 mm) may be visible on the serosal surface, representing meronts. Histological examination of formalin-fixed, hematoxylin-eosin-stained sections reveals the presence of various developmental stages of Eimeria within enterocytes. These include meronts (schizonts) containing merozoites, gamonts (macrogametes and microgametes), and oocysts. The intestinal villi may be blunted or fused, with necrosis and sloughing of epithelial cells. There is an inflammatory infiltrate composed of lymphocytes, plasma cells, and heterophils in the lamina propria. In chronic cases, there may be fibrosis and crypt hyperplasia. The severity of lesions correlates with the species of Eimeria and the parasite load. E. intestinalis causes severe lesions in the ileum, while E. flavescens affects the cecum and colon. Histopathology is also useful to rule out other causes of enteritis, such as bacterial or viral infections. Immunohistochemistry or PCR on tissue samples can be used for species-specific identification.

The treatment of intestinal coccidiosis in rabbits involves a multi-modal approach, including anticoccidial therapy, supportive care, and environmental management. Anticoccidial drugs: The most effective and commonly used drug is toltrazuril (Baycox), administered orally at a dose of 25 mg/kg once daily for 2-3 days, repeated after 5 days if necessary. Toltrazuril is a triazinone derivative that interferes with the respiratory chain of the parasite, and is effective against both asexual and sexual stages. Diclazuril (Clinacox) is another triazinone, given orally at 2-5 mg/kg once daily for 2-3 days. Sulfonamides, such as sulfadimethoxine (Albon), can be used at 50 mg/kg PO on day 1, then 25 mg/kg PO q24h for 5-7 days, but they are less effective and have a higher risk of toxicity. Amprolium (Corid) is a thiamine analog that can be used at 10 mg/kg PO q24h for 5-7 days, but it is less effective in rabbits. Supportive care: Fluid therapy is crucial to correct dehydration and electrolyte imbalances. Subcutaneous (SC) or intravenous (IV) fluids, such as lactated Ringer's solution or Normosol-R, should be administered at a rate of 50-100 ml/kg/day, adjusted based on hydration status. In severe cases, intraosseous (IO) access may be necessary. Nutritional support: Anorexic rabbits should be syringe-fed a high-fiber diet, such as Critical Care (Oxbow) or a homemade gruel of ground pellets and water, at a rate of 10-20 ml/kg per feeding, 3-4 times daily. Probiotics (e.g., Bene-Bac) can help restore normal gut flora. Anti-inflammatory drugs: Non-steroidal anti-inflammatory drugs (NSAIDs) such as meloxicam (Metacam) at 0.2-0.5 mg/kg PO q24h can reduce inflammation and pain. However, caution is advised in dehydrated rabbits due to the risk of renal toxicity. Antibiotics: Secondary bacterial infections may require antibiotics, but they should be used judiciously. Metronidazole (Flagyl) at 20 mg/kg PO q12h can be used for anaerobic overgrowth. Environmental management: Thoroughly clean and disinfect all cages, feeders, and water bottles. Oocysts are resistant to many disinfectants, but 10% ammonia solution or steam cleaning can be effective. Remove feces daily and provide clean, dry bedding. Reduce stocking density and separate affected rabbits from healthy ones. Quarantine new rabbits for at least 2 weeks. In severe outbreaks, prophylactic treatment of all rabbits with toltrazuril may be necessary.

The prognosis for intestinal coccidiosis in rabbits depends on several factors, including the species of Eimeria, the severity of infection, the age and immune status of the rabbit, and the promptness of treatment. With early diagnosis and appropriate treatment, the prognosis is generally good, especially in adult rabbits with mild to moderate infections. However, in young rabbits (4-8 weeks) with severe infections caused by highly pathogenic species such as E. intestinalis or E. flavescens, the prognosis is guarded to poor, with mortality rates up to 50-80% if untreated. Factors that worsen the prognosis include: severe dehydration, hypothermia, secondary bacterial septicemia, and concurrent diseases. Rabbits that survive an acute infection may develop chronic malabsorption and poor growth. The presence of high OPG counts (>100,000) is associated with a poorer prognosis. Response to treatment is usually seen within 24-48 hours, with improvement in fecal consistency and appetite. However, complete recovery may take 1-2 weeks. Reinfection is possible, as immunity is not sterile and is species-specific. Therefore, long-term management and prevention are essential. In chronic cases, rabbits may become carriers and shed oocysts intermittently, posing a risk to other rabbits. Overall, with proper treatment and husbandry, the prognosis for individual rabbits is favorable, but the disease can be devastating in a colony setting.

Follow-up care for rabbits with intestinal coccidiosis is essential to ensure complete recovery and prevent recurrence. Re-check examinations should be scheduled at 1 week and 2 weeks after the initial diagnosis. At each visit, perform a physical examination, assess body weight, and evaluate fecal consistency. Fecal flotation should be repeated to monitor oocyst shedding. A reduction in OPG counts indicates a positive response to treatment. If oocysts are still present after 2 weeks, a second course of anticoccidial therapy may be necessary. Monitor hydration status and electrolyte balance, especially in rabbits that had severe diarrhea. Continue supportive care, including fluid therapy and nutritional support, until the rabbit is eating and drinking normally. Gradually reintroduce a high-fiber diet, such as grass hay and fresh vegetables, to promote gut health. Long-term follow-up should include regular weight checks and fecal examinations every 3-6 months, especially in multi-rabbit households or breeding colonies. Environmental management is crucial: maintain strict sanitation, clean cages daily, and disinfect with 10% ammonia solution or steam. Avoid overcrowding and stress. Quarantine new rabbits for at least 2 weeks and perform fecal examinations before introducing them to the group. In breeding operations, consider prophylactic treatment of does before kindling and kits at weaning. Provide a balanced diet with adequate fiber and avoid sudden dietary changes. Educate owners on the importance of biosecurity and hygiene to prevent future outbreaks.

Pearls: 1. Always perform fecal flotation on multiple rabbits in a group, as some may be subclinical carriers. 2. Toltrazuril is the drug of choice for coccidiosis in rabbits; it is safe and effective. 3. In severe dehydration, use intraosseous fluid administration if IV access is difficult. 4. Provide supportive care with syringe feeding and probiotics to maintain gut motility. 5. Use meloxicam for pain and inflammation, but ensure adequate hydration to avoid renal toxicity. 6. Disinfect cages with 10% ammonia solution, as oocysts are resistant to many disinfectants. 7. In a colony outbreak, treat all rabbits prophylactically with toltrazuril to reduce environmental contamination. 8. Educate owners on the importance of hygiene and quarantine. Pitfalls: 1. Do not use sulfonamides in rabbits with renal disease, as they can crystallize in the urine. 2. Avoid the use of corticosteroids, as they can exacerbate the infection. 3. Do not use antibiotics that disrupt the gut flora, such as clindamycin or lincomycin, as they can cause enterotoxemia. 4. Do not rely solely on fecal flotation; a negative result does not rule out coccidiosis, especially in early infection. 5. Do not overlook the possibility of concurrent infections, such as bacterial enteritis or hepatic coccidiosis. 6. Do not use amprolium in rabbits, as it is less effective and can cause thiamine deficiency. 7. Do not forget to treat the environment; failure to disinfect will lead to reinfection. 8. Do not ignore the importance of nutrition; a high-fiber diet is essential for recovery.

Based on Carpenter's Exotic Animal Formulary (5th edition) and current literature, the following drug protocols are recommended for intestinal coccidiosis in rabbits: 1. Toltrazuril (Baycox): 25 mg/kg PO q24h for 2-3 days, repeat after 5 days if needed. This is the most effective treatment. 2. Diclazuril (Clinacox): 2-5 mg/kg PO q24h for 2-3 days. 3. Sulfadimethoxine (Albon): 50 mg/kg PO on day 1, then 25 mg/kg PO q24h for 5-7 days. Use with caution in rabbits with renal disease. 4. Sulfamethazine: 100 mg/kg PO on day 1, then 50 mg/kg PO q24h for 5 days. 5. Amprolium (Corid): 10 mg/kg PO q24h for 5-7 days. Less effective, but can be used as an alternative. 6. Metronidazole (Flagyl): 20 mg/kg PO q12h for 5-7 days, for secondary anaerobic infections. 7. Meloxicam (Metacam): 0.2-0.5 mg/kg PO q24h for 3-5 days, for pain and inflammation. 8. Fluid therapy: Lactated Ringer's solution or Normosol-R, 50-100 ml/kg/day SC or IV, adjusted based on hydration. In shock, administer 10-20 ml/kg IV over 15-30 minutes. 9. Probiotics: Lactobacillus spp. or Saccharomyces boulardii, 1-2 g/kg PO q24h, to restore gut flora. 10. Nutritional support: Critical Care (Oxbow) or equivalent, 10-20 ml/kg PO q6-8h, via syringe. Always confirm dosages with a current formulary and adjust based on the individual patient's condition.

The literature on intestinal coccidiosis in rabbits is extensive, with numerous studies on the biology, epidemiology, treatment, and prevention of the disease. Key findings from clinical trials and consensus guidelines include: 1. Toltrazuril is highly effective against all intestinal Eimeria species in rabbits, with a single dose of 25 mg/kg showing >95% reduction in oocyst shedding (Marlier et al., 2001). 2. Diclazuril is also effective, but toltrazuril is preferred due to its broader spectrum and safety profile (Peeters et al., 1988). 3. Sulfonamides have been used for decades, but their efficacy is variable, and they are associated with adverse effects such as crystalluria and bone marrow suppression (Harkness & Wagner, 1995). 4. The use of probiotics has been shown to reduce the severity of coccidiosis by modulating the gut microbiota (Kpodekon et al., 2013). 5. Environmental disinfection with 10% ammonia solution or steam is recommended to eliminate oocysts (Varga, 2013). 6. The importance of biosecurity, including quarantine and all-in/all-out management, is emphasized in the BSAVA Manual of Rabbit Medicine (Meredith & Lord, 2014). 7. A study by Pakandl et al. (2008) characterized the life cycle and pathogenicity of E. flavescens, highlighting its high virulence. 8. The ABVP and ECZM consensus guidelines recommend toltrazuril as the first-line treatment for coccidiosis in rabbits (Mayer & Donnelly, 2013). 9. Research on immunity has shown that rabbits develop species-specific immunity after infection, but it is not sterile, and reinfection can occur (Duszynski et al., 2004). 10. A meta-analysis by Li et al. (2016) confirmed the efficacy of toltrazuril in reducing mortality and oocyst shedding in rabbit coccidiosis. Overall, the evidence supports a comprehensive approach combining anticoccidial therapy, supportive care, and environmental management for optimal outcomes.